Defining Value When Launching Biosimilars Treatments Within European Healthcare Systems

Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1677
https://www.valueinhealthjournal.com/article/S1098-3015(15)03753-5/fulltext
Title : Defining Value When Launching Biosimilars Treatments Within European Healthcare Systems
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03753-5&doi=10.1016/j.jval.2015.09.1677
First page : A535
Section Title : Research Podium Presentations - Session 1 and Session 2
Open access? : No
Section Order : 1105
Categories :
Tags :
Regions :
ViH Article Tags :